On the public citation graph
Examination of Methadone Involved Overdoses During the COVID-19 Pandemic
0 signed · 46 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamapsychiatry.2022.1776openalex-snapshot
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs
inferredcites →https://doi.org/10.1002/14651858.cd002207.pub3openalex-snapshot
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
inferredcites →https://doi.org/10.1002/14651858.cd002207.pub4openalex-snapshot
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
inferredcites →https://doi.org/10.1002/pds.980openalex-snapshot
An analysis of the significant variation in psychostimulant use across the U.S.
inferredcites →https://doi.org/10.1016/j.amepre.2018.01.034openalex-snapshot
Trends in Medical Use of Opioids in the U.S., 2006–2016
inferredcites →https://doi.org/10.1016/j.drugalcdep.2017.11.023openalex-snapshot
A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release
inferredcites →https://doi.org/10.1016/j.drugalcdep.2022.109380openalex-snapshot
Xylazine Spreads Across the US: A Growing Component of the Increasingly Synthetic and Polysubstance Overdose Crisis
inferredcites →https://doi.org/10.1016/j.drugalcdep.2022.109575openalex-snapshot
Sex differences in weight gain during medication-based treatment for opioid use disorder: A meta-analysis and retrospective analysis of clinical trial data
inferredcites →https://doi.org/10.1016/j.drugalcdep.2022.109703openalex-snapshot
Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic
inferredcites →https://doi.org/10.1016/j.drugpo.2022.103591openalex-snapshot
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations
inferredcites →https://doi.org/10.1016/j.ijsu.2014.07.013openalex-snapshot
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
inferredcites →https://doi.org/10.1016/j.jsat.2021.108449openalex-snapshot
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19
inferredcites →https://doi.org/10.1016/j.jsat.2021.108514openalex-snapshot
Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
inferredcites →https://doi.org/10.1016/j.jsat.2021.108655openalex-snapshot
“No home to take methadone to”: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston
inferredcites →https://doi.org/10.1055/a-1353-6509openalex-snapshot
Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States
inferredcites →https://doi.org/10.1093/jat/bkac023openalex-snapshot
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
inferredcites →https://doi.org/10.1101/2022.03.09.22272154openalex-snapshot
Reversal of Increases in Methadone Distribution for Opioid Use Disorder in the Us During the COVID-19 Pandemic
inferredcites →https://doi.org/10.1111/add.13238openalex-snapshot
Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial
inferredcites →https://doi.org/10.1111/j.1526-4637.2011.01134.xopenalex-snapshot
An Analysis of the Root Causes for Opioid-Related Overdose Deaths in the United States
inferredcites →https://doi.org/10.1136/bmj.c4851openalex-snapshot
Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland
inferredcites →https://doi.org/10.1177/10600280211028262openalex-snapshot
Pronounced Regional Disparities in United States Methadone Distribution
inferredcites →https://doi.org/10.1186/s12954-021-00535-yopenalex-snapshot
“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives
inferredcites →https://doi.org/10.1186/s13722-021-00281-3openalex-snapshot
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis
inferredcites →https://doi.org/10.1371/journal.pmed.0040296openalex-snapshot
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
inferredcites →https://doi.org/10.15585/mmwr.mm6526a2openalex-snapshot
Trends in Methadone Distribution for Pain Treatment, Methadone Diversion, and Overdose Deaths — United States, 2002–2014
inferredcites →https://doi.org/10.15585/mmwr.mm6612a2openalex-snapshot
Methadone Prescribing and Overdose and the Association with Medicaid Preferred Drug List Policies — United States, 2007–2014
inferredcites →https://doi.org/10.2165/00003088-200241140-00003openalex-snapshot
Interindividual Variability of the Clinical Pharmacokinetics of Methadone
inferredcites →https://doi.org/10.2196/jmir.2810openalex-snapshot
Crowdsourcing Black Market Prices For Prescription Opioids
inferredcites →https://doi.org/10.7759/cureus.18012openalex-snapshot
What Your Death Certificate Says About You May Be Wrong: A Narrative Review on CDC’s Efforts to Quantify Prescription Opioid Overdose Deaths
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1016/j.dadr.2025.100339openalex-snapshot
Methadone-involved overdose deaths in urban and rural communities before and after the public health emergency flexibilities for methadone take-home doses
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2024.111112openalex-snapshot
Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis
inferred← citeshttps://doi.org/10.1016/j.drugpo.2024.104343openalex-snapshot
Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209476openalex-snapshot
Methadone treatment utilization and overdose trends among Medicaid beneficiaries in New Jersey before and during the COVID-19 pandemic
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209509openalex-snapshot
Patient and navigator experiences with the opioid use disorder treatment system in Philadelphia, PA
inferred← citeshttps://doi.org/10.1016/j.therap.2023.06.004openalex-snapshot
Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020
inferred← citeshttps://doi.org/10.1101/2022.03.09.22272154openalex-snapshot
Reversal of Increases in Methadone Distribution for Opioid Use Disorder in the Us During the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.1101/2024.11.10.24317059openalex-snapshot
Dynamic changes in methadone distribution for opioid use disorder treatment from 2019 to 2023
inferred← citeshttps://doi.org/10.1136/bmjopen-2023-073765openalex-snapshot
State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA
inferred← citeshttps://doi.org/10.1136/bmjopen-2023-074845openalex-snapshot
Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-095198openalex-snapshot
Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelines
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-098317openalex-snapshot
Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational study
inferred← citeshttps://doi.org/10.1177/29767342251405994openalex-snapshot
Explaining Variation in VA Opioid Treatment Program Clinical Practice Following Regulatory Reform: A Qualitative Study
inferred← citeshttps://doi.org/10.1177/29768357241272379openalex-snapshot
Methadone Take-Home Policies and Associated Mortality: Permitting versus Non-Permitting States
inferred← citeshttps://doi.org/10.3389/fphar.2023.1163976openalex-snapshot
Variation in adverse drug events of opioids in the United States
inferred← citeshttps://doi.org/10.62401/2531-4122-2025-24openalex-snapshot
Management of patients in an unstable phase of opioid use disorder: Challenges, goals, and emerging evidence on long-acting buprenorphine
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.